Journal articles on the topic 'PI3K-Akt signaling pathway'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'PI3K-Akt signaling pathway.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Urasaki, Yasuyo, Cody Beaumont, Jeffery N. Talbot, David K. Hill, and Thuc T. Le. "Akt3 Regulates the Tissue-Specific Response to Copaiba Essential Oil." International Journal of Molecular Sciences 21, no. 8 (2020): 2851. http://dx.doi.org/10.3390/ijms21082851.
Full textHuang, Shu-ping, Ze-chao Zhang, Yu Chen, Chang-jie Shang, Min Zhu, and Wei-hong Li. "Review of Chinese medicine intervention in PI3K/AKT pathway to regulate fibrosis." Medicine 104, no. 28 (2025): e42957. https://doi.org/10.1097/md.0000000000042957.
Full textLiu, Jiali, Pangao Xu, Dekun Liu, et al. "TCM Regulates PI3K/Akt Signal Pathway to Intervene Atherosclerotic Cardiovascular Disease." Evidence-Based Complementary and Alternative Medicine 2021 (December 16, 2021): 1–11. http://dx.doi.org/10.1155/2021/4854755.
Full textSahu, Rakesh, and Bhaskar Sahu. "Inhibitory potential of Nelumbo nucifera Gaertn extract on the PI3K/AKT/mTOR signaling pathway." Cell Signaling 2, no. 1 (2024): 96–101. http://dx.doi.org/10.46439/signaling.2.037.
Full textMeng, Xianwei, Jun Cui, and Guibin He. "Bcl-2 Is Involved in Cardiac Hypertrophy through PI3K-Akt Pathway." BioMed Research International 2021 (March 12, 2021): 1–8. http://dx.doi.org/10.1155/2021/6615502.
Full textZhang, Qingling, Qi Hu, Jian Li, and Zhirui Lin. "WTX beyond WNT signaling pathway." Visualized Cancer Medicine 4 (2023): 2. http://dx.doi.org/10.1051/vcm/2022006.
Full textLin, Kai, Xinghua Wu, Yuying Qi, Kaiyin Wang, Yunzhu Guan, and Tinghui Hu. "Mechanism of Glucose Transporter Protein 1 Mediating Malignant Behavior in Breast Cancer Through the PI3K/Akt Signaling Pathway." Science of Advanced Materials 15, no. 9 (2023): 1218–23. http://dx.doi.org/10.1166/sam.2023.4533.
Full textLi, Xiao, Xu Feng, Chunkang Chang, Qi He, and Wu Lingyun. "Identification of microRNA-Regulated Pathways through a Integration of Mcrorna-mRNA Microarray and Bioinformatics Analysis in CD34+ Cells of Myelodysplastic Syndromes." Blood 124, no. 21 (2014): 3238. http://dx.doi.org/10.1182/blood.v124.21.3238.3238.
Full textPungsrinont, Thanakorn, Julia Kallenbach, and Aria Baniahmad. "Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer." International Journal of Molecular Sciences 22, no. 20 (2021): 11088. http://dx.doi.org/10.3390/ijms222011088.
Full textSavova, Martina, Liliya Mihaylova, Daniel Tews, Martin Wabitsch, and Milen Georgiev. "Targeting PI3K/AKT signaling pathway in obesity." Targeting PI3K/AKT signaling pathway in obesity 159 (January 11, 2023): 114244. https://doi.org/10.1016/j.biopha.2023.114244.
Full textShorning, Boris Y., Manisha S. Dass, Matthew J. Smalley, and Helen B. Pearson. "The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling." International Journal of Molecular Sciences 21, no. 12 (2020): 4507. http://dx.doi.org/10.3390/ijms21124507.
Full textFan, Demin, Qiang Liu, Fei Wu, et al. "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma." PeerJ 8 (June 1, 2020): e9261. http://dx.doi.org/10.7717/peerj.9261.
Full textWiese, Wojciech, Julia Barczuk, Olga Racinska, et al. "PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities." Cancers 15, no. 21 (2023): 5297. http://dx.doi.org/10.3390/cancers15215297.
Full textLi-Jun, Zhang, Huang Zhi-Li, Wang Yan та Li Qiao-Qiao. "Expression of PI3K/AKT Signaling Pathway in IFN-β-induced Differentiation of Human Mesenchymal Stem Cells into Chondroblasts". International Journal of Sciences Volume 8, № 2019-08 (2019): 23–28. https://doi.org/10.5281/zenodo.3979967.
Full textNepstad, Ina, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, and Håkon Reikvam. "The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells." International Journal of Molecular Sciences 21, no. 8 (2020): 2907. http://dx.doi.org/10.3390/ijms21082907.
Full textSmit, Daniel J., Laure Cayrefourcq, Marie-Therese Haider, et al. "High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors." Cells 9, no. 9 (2020): 2129. http://dx.doi.org/10.3390/cells9092129.
Full textXu, Miaomiao, Xiaoguang Liu, Peng Bao, et al. "Skeletal Muscle CSE Deficiency Leads to Insulin Resistance in Mice." Antioxidants 11, no. 11 (2022): 2216. http://dx.doi.org/10.3390/antiox11112216.
Full textDeng, Shuo, Hin Chong Leong, Arpita Datta, Vennila Gopal, Alan Prem Kumar, and Celestial T. Yap. "PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression." Cancers 14, no. 7 (2022): 1652. http://dx.doi.org/10.3390/cancers14071652.
Full textNarayanankutty, Arunaksharan. "Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment." Recent Patents on Anti-Cancer Drug Discovery 15, no. 3 (2020): 188–99. http://dx.doi.org/10.2174/1574892815666200910164641.
Full textLanghammer, Tina-Susann, Catrin Roolf, Saskia Krohn та ін. "PI3K/Akt Signaling Interacts With Wnt/β-Catenin Signaling But Does Not Induce An Accumulation Of β-Catenin In The Nucleus Of Acute Lymphoblastic Leukemia Cell Lines". Blood 122, № 21 (2013): 4886. http://dx.doi.org/10.1182/blood.v122.21.4886.4886.
Full textLi, Xiaojuan, Yunping Tang, Fangmiao Yu, et al. "Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway." Marine Drugs 16, no. 9 (2018): 325. http://dx.doi.org/10.3390/md16090325.
Full textSicurella, Mariaconcetta, Marica De Chiara, and Luca Maria Neri. "Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death." Cells 14, no. 4 (2025): 269. https://doi.org/10.3390/cells14040269.
Full textSingh, Sudha B., Cody A. Braun, Amanda Carroll-Portillo, Cristina N. Coffman та Henry C. Lin. "Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner". Microorganisms 12, № 9 (2024): 1833. http://dx.doi.org/10.3390/microorganisms12091833.
Full textCohen, Shenhav, Donghoon Lee, Bo Zhai, Steven P. Gygi, and Alfred L. Goldberg. "Trim32 reduces PI3K–Akt–FoxO signaling in muscle atrophy by promoting plakoglobin–PI3K dissociation." Journal of Cell Biology 204, no. 5 (2014): 747–58. http://dx.doi.org/10.1083/jcb.201304167.
Full textSanchez, Vanessa, Cydney Nichols, Hye Kim, Eun Gang, and Yong-Mi Kim. "Targeting PI3K Signaling in Acute Lymphoblastic Leukemia." International Journal of Molecular Sciences 20, no. 2 (2019): 412. http://dx.doi.org/10.3390/ijms20020412.
Full textDunn, Ewan F., Rachel Fearns, and John H. Connor. "Akt Inhibitor Akt-IV Blocks Virus Replication through an Akt-Independent Mechanism." Journal of Virology 83, no. 22 (2009): 11665–72. http://dx.doi.org/10.1128/jvi.01092-09.
Full textTuo, Bi-Guang, Guo-Rong Wen, and Ursula Seidler. "Phosphatidylinositol 3-kinase is involved in prostaglandin E2-mediated murine duodenal bicarbonate secretion." American Journal of Physiology-Gastrointestinal and Liver Physiology 293, no. 1 (2007): G279—G287. http://dx.doi.org/10.1152/ajpgi.00488.2006.
Full textLing, Mingfa, Lulu Quan, Xumin Lai, et al. "VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway." International Journal of Molecular Sciences 22, no. 24 (2021): 13352. http://dx.doi.org/10.3390/ijms222413352.
Full textMehra, Siddharth, Nilesh Deshpande, and Nagaraj Nagathihalli. "Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress." Cancers 13, no. 17 (2021): 4434. http://dx.doi.org/10.3390/cancers13174434.
Full textSu, Yu-Chieh, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen, and Po-Jen Chen. "Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas." International Journal of Molecular Sciences 23, no. 24 (2022): 15749. http://dx.doi.org/10.3390/ijms232415749.
Full textMarzec, Michal, Xiaobin Liu, Monika Kasprzycka, et al. "IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes." Blood 111, no. 4 (2008): 2181–89. http://dx.doi.org/10.1182/blood-2007-06-095182.
Full textSingh, Shikha Satendra. "Characterization of a novel regulator of AKT/mTOR signaling in gastric cancer." Journal of Clinical Oncology 34, no. 4_suppl (2016): 68. http://dx.doi.org/10.1200/jco.2016.34.4_suppl.68.
Full textZhao, Xingsheng, Yu Ren, Hongkun Ren, et al. "The mechanism of myocardial fibrosis is ameliorated by myocardial infarction-associated transcript through the PI3K/Akt signaling pathway to relieve heart failure." Journal of International Medical Research 49, no. 7 (2021): 030006052110314. http://dx.doi.org/10.1177/03000605211031433.
Full textWang, Bing-jie, Wang-long Zheng, Nan-nan Feng, et al. "The Effects of Autophagy and PI3K/AKT/m-TOR Signaling Pathway on the Cell-Cycle Arrest of Rats Primary Sertoli Cells Induced by Zearalenone." Toxins 10, no. 10 (2018): 398. http://dx.doi.org/10.3390/toxins10100398.
Full textBang, Jieun, Mihyeon Jun, Soyun Lee, Hyuk Moon, and Simon Weonsang Ro. "Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma." Pharmaceutics 15, no. 8 (2023): 2130. http://dx.doi.org/10.3390/pharmaceutics15082130.
Full textShowler, Kaye, Mayumi Nishimura, Kazuhiro Daino, et al. "Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas." Journal of Radiation Research 58, no. 2 (2016): 183–94. http://dx.doi.org/10.1093/jrr/rrw097.
Full textWang, Xiao-Mei, Min Yao, Shu-Xia Liu, Jun Hao, Qing-Juan Liu, and Feng Gao. "Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis." American Journal of Physiology-Renal Physiology 306, no. 2 (2014): F205—F213. http://dx.doi.org/10.1152/ajprenal.90005.2013.
Full textFresno, Vara Juan Angel, Castro Javier de, and Manuel González-Barón. "PI3K/Akt signalling pathway and cance." Cancer Treatment Reviews 30 (April 1, 2004): 193–204. https://doi.org/10.1016/j.ctrv.2003.07.007.
Full textHuang, Lu, Qiong Yang, Huihong Chen, Zhenggeng Wang, Qi Liu, and Shuhua Ai. "Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway." Open Medicine 17, no. 1 (2022): 626–37. http://dx.doi.org/10.1515/med-2022-0453.
Full textDarici, Salihanur, Hazem Alkhaldi, Gillian Horne, Heather G. Jørgensen, Sandra Marmiroli, and Xu Huang. "Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence." Journal of Clinical Medicine 9, no. 9 (2020): 2934. http://dx.doi.org/10.3390/jcm9092934.
Full textLi, Jing, Xien Wang, Feng Xu, Yingjie Wu, Feizhen Xia, and Peng Wan. "Molecular Mechanism of Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway-Mediated Autophagy in Gastric Cancer." Journal of Biomaterials and Tissue Engineering 10, no. 2 (2020): 223–27. http://dx.doi.org/10.1166/jbt.2020.2234.
Full textLiu, Wei, Hongmiao Ren, Jihao Ren, et al. "The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma." Mediators of Inflammation 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/651207.
Full textCornejo, Melanie G., Stephen M. Sykes, Cristina Lo Celso, et al. "A Regulatory Network Between Notch and AKT Signaling Pathways Differentially Controls Megakaryocyte Development From Hematopoietic Stem or Committed Progenitor Cells." Blood 114, no. 22 (2009): 384. http://dx.doi.org/10.1182/blood.v114.22.384.384.
Full textYuan, Yeqin, Huizhi Long, Ziwei Zhou, Yuting Fu, and Binyuan Jiang. "PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds." Biomolecules 13, no. 1 (2023): 93. http://dx.doi.org/10.3390/biom13010093.
Full textUrasaki, Yasuyo, Cody Beaumont, Michelle Workman, Jeffery N. Talbot, David K. Hill, and Thuc T. Le. "Fast-Acting and Receptor-Mediated Regulation of Neuronal Signaling Pathways by Copaiba Essential Oil." International Journal of Molecular Sciences 21, no. 7 (2020): 2259. http://dx.doi.org/10.3390/ijms21072259.
Full textDas, Margaret, Erica Scappini, Negin P. Martin та ін. "Regulation of Neuron Survival through an Intersectin-Phosphoinositide 3′-Kinase C2β-AKT Pathway". Molecular and Cellular Biology 27, № 22 (2007): 7906–17. http://dx.doi.org/10.1128/mcb.01369-07.
Full textCarón, Rubén W., Adly Yacoub, Xiaoyu Zhu, et al. "H-RAS V12–induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent." Molecular Cancer Therapeutics 4, no. 2 (2005): 243–55. http://dx.doi.org/10.1158/1535-7163.243.4.2.
Full textJung, Eun-Ju, Jae-Hwan Jo, Claudine Uwamahoro, et al. "Ritonavir Has Reproductive Toxicity Depending on Disrupting PI3K/PDK1/AKT Signaling Pathway." Toxics 12, no. 1 (2024): 73. http://dx.doi.org/10.3390/toxics12010073.
Full textXiao, Quan, Yun Teng, Changming Xu, et al. "Role of PI3K/AKT Signaling Pathway in Nucleus Pulposus Cells." BioMed Research International 2021 (July 1, 2021): 1–9. http://dx.doi.org/10.1155/2021/9941253.
Full textAlqahtani, Ali, Hazem S. K. Ayesh, and Hafez Halawani. "PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis." Cancers 12, no. 1 (2019): 93. http://dx.doi.org/10.3390/cancers12010093.
Full text